Dave graduated from Cambridge University in 1999, having previously obtained a BA in Virology and Immunology. Following completion of a medical rotation and after spending 2 years in New Zealand, he returned to his native South Yorkshire in 2006 to commence his joint training in Medical Microbiology and Infectious Diseases in Sheffield and was appointed as a Consultant Microbiologist at Sheffield Teaching Hospitals in 2012 and is lead consultant for management of infections in the immunocompromised and for fungal disease. Dave was appointed Academic lead for the Laboratory Medicine Directorate in 2015 with responsibility for ensuring that we are responsive to the needs of researchers across STH as well as building research momentum within the directorate. He is an active member of the British Infection Association and has served on its council since 2010. He also serves on the research grants committee of the Healthcare Infection Society and is Assistant Editor of the Journal of Infection. His primary research interests lie in healthcare infection control and the clinical application of molecular diagnostics.
Peer Reviewed Publications and Book Chapters
“The clinical and phenotypical assessment of seronegative villous atrophy; a prospective UK centre experience evaluating 200 adult cases over a 15-year period (2000-2015).”Aziz I, Peerally MF, Barnes JH, Kandasamy V, Whiteley JC, Partridge D, Vergani P, Cross SS, Green PH, Sanders DS. Gut. 2016 (Epub ahead of print)
“Seeing a cause for blindness in severe pancreatitis.” Hopper AD, Gosling D, Patwary S, Partridge D, Peterson M. Gut. 2016 Jan;65(1):32, 46.
“Case report of a successfully treated gentamicin and ciprofloxacin resistant Serratia marcescens prosthetic joint infection.” Cannon TA, Partridge DG, Boden RA, Townsend R, Stockley I. Ann R Coll Surg Engl. 2014 Nov;96(8):e23-5.
“A unique case of phaeohyphomycosis subretinal abscess in a patient with arthropathy and lung pathology.” Matthews BJ, Partridge D, Sheard RM, Rennie IG, Mudhar HS. Indian J Ophthalmol. 2013 Dec;61(12):763-5.
“Lessons from a large norovirus outbreak: impact of viral load, patient age and ward design on duration of symptoms and shedding and likelihood of transmission.” Partridge DG, Evans CM, Raza M, Kudesia G, Parsons HK. J Hosp Infect. 2012 May;81(1):25-30.
“Outpatient parenteral antibiotic therapy for infective endocarditis: a review of 4 years' experience at a UK centre.” Partridge DG, O'Brien E, Chapman AL. Postgrad Med J. 2012 Jul;88(1041):377-81.
“HIV testing in colposcopy and termination of pregnancy services: a missed opportunity?” Briggs A, Partridge DG, Bates S. J Fam Plann Reprod Health Care. 2011 Oct;37(4):201-3.
“Imported human fascioliasis, United Kingdom.” Chand MA, Herman JS, Partridge DG, Hewitt K, Chiodini PL. Emerg Infect Dis. 2009 15(11):1876-7
“HIV Testing: The Boundaries. A Survey of HIV Testing Practices and Barriers to More Widespread testing in a British Teaching Hospital.” DG Partridge, P Collini, MW McKendrick. Int. J. STD and AIDS 2009 20(6):427-8.
“The treatment of varicella-zoster virus infection and its complications.” DG Partridge, MW McKendrick. Expert Opin. Pharmacother. 2009 10(5):797-812.
“Vibrio Vulnificus: An Unusual Mode of Acquisition and Novel Use of Rapid Susceptibility Testing.” DG Partridge, S Larkin, R Townsend, HK Parsons. J. Clin. Path. 2009 62(4):370-2.
“Prosthetic valve endocarditis caused by Pseudomonas mosselii” E. McLellan, DG Partridge. J Med. Microbiol. 2009; 58: 144-145
“Simple Quality Improvement Interventions Reduce Unnecessary Intravascular Device Dwell Time.” Stephen J. McBride; David W. Scott; David G. Partridge; Simon E. Briggs. Infect Control Hosp. Epidemiol. 2008; 29:469-470